| Form type | Sec Links | Description | Filing date | Reporting date |
|---|
Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| SC 13G/A | Report | SCHEDULE 13G/A | Nov 1, 2024 | |
| SC 13G | Report | Oct 18, 2024 | ||
| SC 13G/A | Report | SCHEDULE 13G/A | Oct 18, 2024 | |
| SC 13G | Report | Jul 30, 2024 | ||
| SC 13G/A | Report | SCHEDULE 13G/A | May 20, 2024 | |
| SC 13G | Report | Apr 10, 2024 | ||
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 13, 2024 | |
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 2, 2024 | |
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 2, 2024 | |
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 2, 2024 | |
| SC 13G/A | Report | Jan 30, 2024 | ||
| SC 13G/A | Report | Jan 26, 2024 | ||
| SC 13G | Report | SCHWEDULE 13G | Jan 24, 2024 | |
| SC 13G/A | Report | Feb 10, 2023 | ||
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 9, 2023 | |
| SC 13G/A | Report | Jan 31, 2023 | ||
| SC 13G/A | Report | SCHEDULE 13G/A | Jan 27, 2023 | |
| SC 13G/A | Report | SCHEDULE 13G/A FOR PROTAGONIST THERAPEUTICS, INC. ON BEHALF OF JOHNSON & JOHNSON | Jan 11, 2023 | |
| SC 13G/A | Report | SC 13G/A | Nov 14, 2022 | |
| SC 13G/A | Report | Feb 14, 2022 | ||
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 10, 2022 | |
| SC 13G | Report | SCHEDULE 13G FOR CVRX, INC. | Feb 7, 2022 | |
| SC 13G/A | Report | SCHEDULE 13G-A FOR PHASEBIO PHARMACEUTICALS, INC. | Feb 1, 2022 | |
| SC 13G/A | Report | Feb 1, 2022 | ||
| SC 13G | Report | Feb 12, 2021 | ||
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 10, 2021 | |
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 2, 2021 | |
| SC 13G/A | Report | Jan 29, 2021 | ||
| SC 13G | Report | SCHEDULE 13G FOR FUSION PHARMACEUTICALS INC. BY JOHNSON & JOHNSON | Jul 6, 2020 | |
| SC 13G | Report | Feb 13, 2020 | ||
| SC 13G/A | Report | SCHEDULE 13G/A | Feb 12, 2020 | |
| SC 13G/A | Report | Feb 10, 2020 | ||
| SC 13G/A | Report | SCHEDULE 13G FOR PHASEBIO PHARMACEUTICALS, INC. BY JOHNSON & JOHNSON, DATED 12.3 | Jan 17, 2020 | |
| SC 13G/A | Report | SCH 13GA - FILER JOHNSON & JOHNSON, SUBJECT - PROVENTION BIO, DTD 12/31/19 | Jan 17, 2020 | |
| SC 13G | Report | SC 13G | Nov 26, 2019 | |
| SC 13G | Report | SCHEDULE 13G FOR MEIRAGTX HOLDINGS PLC BY JOHNSON & JOHNSON. | Mar 4, 2019 | |
| SC 13G | Report | JOHNSON & JOHNSON | Feb 13, 2019 | |
| SC 13G/A | Report | Feb 11, 2019 | ||
| SC 13G/A | Report | Feb 11, 2019 | ||
| SC 13G | Report | SCHEDULE 13G FOR PHASEBIO PHARMACEUTICALS, INC. BY JOHNSON & JOHNSON | Jan 22, 2019 | |
| SC 13G | Report | SCHEDULE 13G FOR PROVENTION BIO, INC. BY JOHNSON & JOHNSON | Jan 22, 2019 | |
| SC 13G/A | Report | SCHEDULE 13G-A FOR MERUS N.V. BY JOHNSON & JOHNSON | Jan 22, 2019 | |
| SC 13G/A | Report | SCHEDULE 13G-A FOR MACROGENICS, INC. BY JOHNSON & JOHNSON | Jan 22, 2019 | |
| SC 13G/A | Report | SCHEDULE 13G-A FOR ADURO BIOTECH, INC. BY JOHNSON & JOHNSON | Jan 22, 2019 | |
| SC 13G/A | Report | SCHEDULE 13G-A FOR ALDEYRA THERAPEUTICS, INC. BY JOHNSON & JOHNSON | Jan 22, 2019 | |
| SC 13G/A | Report | SCHEDULE 13G-A FOR GI DYNAMICS, INC. BY JOHNSON & JOHNSON | Jan 22, 2019 | |
| SC 13G | Report | JOHNSON & JOHNSON | Feb 14, 2018 | |
| SC 13G/A | Report | Feb 9, 2018 | ||
| SC 13G/A | Report | Feb 8, 2018 | ||
| SC 13G/A | Report | SCHED13G/A SUBMITTED ON 1-16-18 FOR JOHNSON & JOHNSON AND TRACON PHARMACEUTICALS | Jan 22, 2018 |